Therapeutic Classifications


We constantly aim to provide our clients with APIs coupled with complete technical and regulatory documentation (TDP / CTD / E-DMF / CEP / US-DMF etc…). Our APIs originate from EU-GMP certified and US-FDA approved production facilities.

Our supported Therapeutic Classifications include:

We constantly aim to provide top technical support and full regulatory documentation (TDP / CTD / E-DMF / CEP / US-DMF etc…) even for the most recently approved APIs, originating from EU-GMP certified and US-FDA approved production facilities. Many of the above APIs are manufactured via non-infringing routes of synthesis and would be suitable for Paragraph IV challenges / early launch in regulated markets.

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. We’re working to update our website to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service